Drug Interaction Report
1 potential interaction and/or warning found for the following 2 drugs:
- Profilnine (factor ix complex)
- tranexamic acid
Interactions between your drugs
tranexamic acid factor IX complex
Applies to: tranexamic acid, Profilnine (factor ix complex)
GENERALLY AVOID: Due to additive or synergistic pharmacodynamic effects, the risk of thrombosis may be increased when antifibrinolytic agents (e.g., aminocaproic acid, aprotinin, tranexamic acid) are coadministered with other hemostatic agents such as factor VIII inhibitor bypassing fraction, factor IX complex, prothrombin complex, or direct oral anticoagulant reversal agents.
MANAGEMENT: Concomitant administration of antifibrinolytic agents with other hemostatic agents should generally be avoided. Consult the manufacturer's product labeling for recommended dosing intervals between products.
References (4)
- (2001) "Product Information. Amicar (aminocaproic acid)." Immunex Corporation
- (2001) "Product Information. Cyklokapron (tranexamic acid)." Pharmacia and Upjohn
- (2022) "Product Information. Lysteda (tranexamic acid)." Xanodyne Pharmaceuticals Inc
- (2023) "Product Information. Tranexamic Acid (tranexamic acid)." Armas Pharmaceuticals, Inc.
Drug and food/lifestyle interactions
No alcohol/food interactions were found with the drugs in your list. However, this does not necessarily mean no food interactions exist. Always consult your healthcare provider.
Therapeutic duplication warnings
No duplication warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
Report options
- Switch to consumer interaction data
- Email this report to a friend, doctor, or patient
- Ask questions, find answers
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Lysteda
Lysteda (tranexamic acid) is used to treat heavy menstrual bleeding. Includes Lysteda side effects ...
Cyklokapron
Cyklokapron is used for bleeding disorder, factor ix deficiency, hemophilia a
Ozempic
Learn about Ozempic (semaglutide) for type 2 diabetes treatment, weight management, cardiovascular ...
Idelvion
Idelvion (coagulation factor ix recombinant, albumin fusion protein) is a long-acting, injectable ...
Alprolix
Alprolix is used in hemophilia B to help control and prevent bleeding, it is a coagulation Factor ...
BeneFix
BeneFix (coagulation factor IX) is a once-weekly, injectable, treatment for hemophilia B that may ...
Rebinyn
Rebinyn (glycopegylated coagulation factor IX [recombinant]) is an injectable, long-lasting, human ...
Bebulin
Bebulin is used for factor ix deficiency, factor vii deficiency, hemophilia a with inhibitors ...
Coagulation factor ix
Coagulation factor ix is used for factor ix deficiency, hemophilia b
Learn more
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Check Interactions
To view an interaction report containing 4 (or more) medications, please sign in or create an account.
Save Interactions List
Sign in to your account to save this drug interaction list.